These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 761675)

  • 1. Experience with two different medicated intrauterine devices: a comparative study of the Progestasert and Nova-T.
    Fylling P; Fagerhol M
    Fertil Steril; 1979 Feb; 31(2):138-41. PubMed ID: 761675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
    Nilsson CG; Allonen H; Diaz J; Luukkainen T
    Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrauterine contraception with Nova-T and copper-T-200 during three years.
    Nygren KG; Nielsen NC; Pyörälä T; Allonen H; Luukkainen T
    Contraception; 1981 Nov; 24(5):529-42. PubMed ID: 7032839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A collaborative study of the progesterone intrauterine device (Progestasert). The World Health Organization Task Force on Methods for the Regulation of Implantation.
    Newton J; Szontagh F; Lebech P; Rowe P
    Contraception; 1979 Jun; 19(6):575-89. PubMed ID: 487808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
    Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M
    Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
    Chi IC
    Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short notes on intrauterine devices.
    Indian J Med Sci; 1990 May; 44(5):129-33. PubMed ID: 2397950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy.
    French R; Van Vliet H; Cowan F; Mansour D; Morris S; Hughes D; Robinson A; Proctor T; Summerbell C; Logan S; Helmerhorst F; Guillebaud J
    Cochrane Database Syst Rev; 2004; 2004(3):CD001776. PubMed ID: 15266453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of the clinical performance of two copper-releasing IUDs, Nova-T & Copper-T-200 in Lagos, Nigeria.
    Oyediran MA; Akinla O
    Contraception; 1980 Aug; 22(2):115-22. PubMed ID: 7004771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonally impregnated intrauterine systems (IUSs), versus other forms of reversible contraceptives as effective methods of preventing pregnancy.
    French R; Cowan F; Mansour D; Morris S; Hughes D; Robinson A; Proctor T; Summerbell C; Logan S; Guillebaud J
    Cochrane Database Syst Rev; 2001; (2):CD001776. PubMed ID: 11406007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial.
    Andersson K; Odlind V; Rybo G
    Contraception; 1994 Jan; 49(1):56-72. PubMed ID: 8137626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of intrauterine devices. II. Intrauterine devices and pelvic inflammatory disease and ectopic pregnancy.
    Malhotra N; Chaudhury RR
    Obstet Gynecol Surv; 1982 Jan; 37(1):1-8. PubMed ID: 7054735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five years' experience with levonorgestrel-releasing IUDs.
    Luukkainen T; Allonen H; Haukkamaa M; Lähteenmäki P; Nilsson CG; Toivonen J
    Contraception; 1986 Feb; 33(2):139-48. PubMed ID: 3084167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five years' experience of intrauterine contraception with the Nova-T and the Copper-T-200.
    Luukkainen T; Allonen H; Nielsen NC; Nygren KG; Pyörälä T
    Am J Obstet Gynecol; 1983 Dec; 147(8):885-92. PubMed ID: 6650625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrauterine steroid contraceptives.
    Scholten PC; Christaens GC; Haspels AA
    Wien Med Wochenschr; 1987 Nov; 137(20-21):479-83. PubMed ID: 3131966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrauterine devices.
    Mccarthy TG; Ratnam SS
    Contemp Rev Obstet Gynaecol; 1992 Oct; 4(4):215-22. PubMed ID: 12345158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T.
    Andersson K; Batar I; Rybo G
    Contraception; 1992 Dec; 46(6):575-84. PubMed ID: 1493717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability].
    Custo GM; Cosmi EV
    Patol Clin Ostet Ginecol; 1984; 12(4):331-43. PubMed ID: 12340352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of three copper IUDs (MLCu250, MLCu375 and Nova-T).
    Bratt H; Skjeldestad FE; Cullberg Valentin K
    Acta Obstet Gynecol Scand; 1988; 67(3):247-51. PubMed ID: 3051876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.